130 related articles for article (PubMed ID: 22920090)
1. Quantitative structure-activity relationships of imidazole-containing farnesyltransferase inhibitors using different chemometric methods.
Shayanfar A; Ghasemi S; Soltani S; Asadpour-Zeynali K; Doerksen RJ; Jouyban A
Med Chem; 2013 May; 9(3):434-48. PubMed ID: 22920090
[TBL] [Abstract][Full Text] [Related]
2. 2D-QSAR study of some 2,5-diaminobenzophenone farnesyltransferase inhibitors by different chemometric methods.
Ghanbarzadeh S; Ghasemi S; Shayanfar A; Ebrahimi-Najafabadi H
EXCLI J; 2015; 14():484-95. PubMed ID: 26600747
[TBL] [Abstract][Full Text] [Related]
3. Application of GA-MLR for QSAR Modeling of the Arylthioindole Class of Tubulin Polymerization Inhibitors as Anticancer Agents.
Ahmadi S; Habibpour E
Anticancer Agents Med Chem; 2017; 17(4):552-565. PubMed ID: 27528182
[TBL] [Abstract][Full Text] [Related]
4. Quantitative Structure-Activity Relationship Study of Camptothecin Derivatives as Anticancer Drugs Using Molecular Descriptors.
Ahmadinejad N; Shafiei F
Comb Chem High Throughput Screen; 2019; 22(6):387-399. PubMed ID: 31284856
[TBL] [Abstract][Full Text] [Related]
5. Farnesyltransferase inhibitors: a comprehensive review based on quantitative structural analysis.
Moorthy NS; Sousa SF; Ramos MJ; Fernandes PA
Curr Med Chem; 2013; 20(38):4888-923. PubMed ID: 24059235
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and activity of 1-aryl-1'-imidazolyl methyl ethers as non-thiol farnesyltransferase inhibitors.
Li Q; Wang GT; Li T; Gwaltney SL; Woods KW; Claiborne A; Wang X; Gu W; Cohen J; Stoll VS; Hutchins C; Frost D; Rosenberg SH; Sham HL
Bioorg Med Chem Lett; 2004 Nov; 14(21):5371-6. PubMed ID: 15454229
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of 1-benzyl-5-(3-biphenyl-2-yl-propyl)-1H-imidazole as novel farnesyltransferase inhibitor.
Lin NH; Wang L; Wang X; Wang GT; Cohen J; Gu WZ; Zhang H; Rosenberg SH; Sham HL
Bioorg Med Chem Lett; 2004 Oct; 14(20):5057-62. PubMed ID: 15380198
[TBL] [Abstract][Full Text] [Related]
8. Insights into the structural requirements of farnesyltransferase inhibitors as potential anti-tumor agents based on 3D-QSAR CoMFA and CoMSIA models.
Puntambekar DS; Giridhar R; Yadav MR
Eur J Med Chem; 2008 Jan; 43(1):142-54. PubMed ID: 17448576
[TBL] [Abstract][Full Text] [Related]
9. A Structure-Activity Relationship Study of Imidazole-5-Carboxylic Acid Derivatives as Angiotensin II Receptor Antagonists Combining 2D and 3D QSAR Methods.
Sharma MC
Interdiscip Sci; 2016 Mar; 8(1):1-10. PubMed ID: 26202941
[TBL] [Abstract][Full Text] [Related]
10. 2D- and 3D-QSAR Modeling of Imidazole-Based Glutaminyl Cyclase Inhibitors.
Al-Attraqchi OHA; Venugopala KN
Curr Comput Aided Drug Des; 2020; 16(6):682-697. PubMed ID: 31533602
[TBL] [Abstract][Full Text] [Related]
11. Comparative chemometric modeling of cytochrome 3A4 inhibitory activity of structurally diverse compounds using stepwise MLR, FA-MLR, PLS, GFA, G/PLS and ANN techniques.
Roy K; Pratim Roy P
Eur J Med Chem; 2009 Jul; 44(7):2913-22. PubMed ID: 19128860
[TBL] [Abstract][Full Text] [Related]
12. 2D MI-DRAGON: a new predictor for protein-ligands interactions and theoretic-experimental studies of US FDA drug-target network, oxoisoaporphine inhibitors for MAO-A and human parasite proteins.
Prado-Prado F; García-Mera X; Escobar M; Sobarzo-Sánchez E; Yañez M; Riera-Fernandez P; González-Díaz H
Eur J Med Chem; 2011 Dec; 46(12):5838-51. PubMed ID: 22005185
[TBL] [Abstract][Full Text] [Related]
13. A QSAR analysis of 2-phenoxy-N-substituted acetamide analogues as hypoxia-inducible factor-1(HIF-1) inhibitors: a rational approach to anticancer drug design.
Noolvi MN; Patel HM; Kamboj S
Med Chem; 2012 Jul; 8(4):599-614. PubMed ID: 22530909
[TBL] [Abstract][Full Text] [Related]
14. Imidazole-containing farnesyltransferase inhibitors: 3D quantitative structure-activity relationships and molecular docking.
Xie A; Odde S; Prasanna S; Doerksen RJ
J Comput Aided Mol Des; 2009 Jul; 23(7):431-48. PubMed ID: 19479325
[TBL] [Abstract][Full Text] [Related]
15. Predictive QSAR modeling of CCR5 antagonist piperidine derivatives using chemometric tools.
Roy K; Mandal AS
J Enzyme Inhib Med Chem; 2009 Feb; 24(1):205-23. PubMed ID: 18608745
[TBL] [Abstract][Full Text] [Related]
16. QSAR Modeling of the Arylthioindole Class of Colchicine Polymerization Inhibitors as Anticancer Agents.
Habibpour E; Ahmadi S
Curr Comput Aided Drug Des; 2017; 13(2):143-159. PubMed ID: 28120704
[TBL] [Abstract][Full Text] [Related]
17. New Research for Quinazoline-2,4-diones as HPPD Inhibitors Based on 2D-MLR and 3D-QSAR Models.
Fu Y; Sun YN; Cao HF; Yi KH; Zhao LX; Li JZ; Ye F
Comb Chem High Throughput Screen; 2017; 20(9):748-759. PubMed ID: 28637410
[TBL] [Abstract][Full Text] [Related]
18. QSAR study on hetaryl imidazoles: a novel dual inhibitor of VEGF receptors I and II.
Patel A; Karthikeyan C; Moorthy NS; Trivedi P
Med Chem; 2010 Jan; 6(1):24-9. PubMed ID: 20402657
[TBL] [Abstract][Full Text] [Related]
19. Modeling Physico-Chemical Properties of Quinolone Derivatives Using GA-MLR as a Computational Study.
Shirmohammadi M; Mohammadinasab E; Bayat Z
Curr Comput Aided Drug Des; 2020; 16(6):667-681. PubMed ID: 31830893
[TBL] [Abstract][Full Text] [Related]
20. Docking and QSAR Studies of 1,4-Dihydropyridine Derivatives as Anti- Cancer Agent.
Mollazadeh S; Shamsara J; Iman M; Hadizadeh F
Recent Pat Anticancer Drug Discov; 2017; 12(2):174-185. PubMed ID: 28137213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
